Logo

American Heart Association

  10
  0


Final ID: TMP101

Clinical and Genetic Risk Factors Predict Atrial Fibrillation Based on Hypertrophic Cardiomyopathy

Abstract Body: Background: Clinical and genetic predispositions are significant in predicting atrial fibrillation (AF); however, their role in patients with hypertrophic cardiomyopathy (HCM) remains unclear. This study aims to elucidate the impact of clinical and genetic risk factors on the development of AF in patients with and without HCM.
Methods: This retrospective analysis involved data from the UK Biobank cohort, collected between 2006 and 2010. The cohort comprised 500,543 individuals: 1,361 diagnosed with and 499,182 without HCM. Participants were stratified based on their validated polygenic risk score for AF: the bottom 10% constituted the low-risk genetic group, the top 10% comprised the high-risk genetic group, and the remainder comprised the intermediate-risk genetic group. We assessed the incidence of AF and cardiovascular complications and analyzed its predictors, including genetic risk.
Results: We examined 1,180 patients with HCM (mean age 61.1±7.1, 63.0% male) and 476,238 participants without HCM (mean age 57.0±8.1, 45.3% male). During the 11.6-year follow-up period, the age- and sex-adjusted AF incidence rates for the low-, intermediate-, and high-risk genetic groups were 2.4, 3.6, and 5.4 per 100 person-years in patients with HCM and 0.2, 0.5, and 1.0 per 100 person-years in participants without HCM, respectively. Genetic risk was a less significant predictor of AF in HCM groups (HR:2.51, 95%CI:1.59–3.98) than in non-HCM groups (HR:4.77, 95%CI:4.47–5.09) (P=0.008 for interaction). Clinical risk factors, including male sex, body mass index, hypertension, and previous myocardial infarction, were less significant predictors of AF in patients with HCM than in those without HCM. A high genetic risk was significantly associated with the risk of cardiovascular complications in participants with and without HCM.
Conclusions: Genetic predisposition was associated with the development of AF and cardiovascular complications in people with and without HCM; this association was weaker in the HCM group.
  • Kim, Jin-bae  ( kyung Hee University , Seoul , Korea (the Republic of) )
  • Sohn, Young Sul  ( Kyung Hee University , Seoul , Korea (the Republic of) )
  • Author Disclosures:
    Jin-Bae Kim: DO NOT have relevant financial relationships | Young Sul Sohn: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Risk Factors and Prevention Moderated Poster Tour II

Thursday, 02/06/2025 , 06:00PM - 07:00PM

Moderated Poster Abstract Session

More abstracts on this topic:
Aggressive Risk factor REduction STudy for Atrial Fibrillation (ARREST-AF) implications for ablation outcomes: A Randomized Clinical Trial

Pathak Rajeev, Mahajan Rajiv, Abhayaratna Walter, Kalman Jonathan, Sanders Prashanthan, Elliott Adrian, Lau Dennis, Middeldorp Melissa, Linz Dominik, Fitzgerald John, Ariyaratnam Jonathan, Malik Varun, Noubiap Jean Jacques

Acacetin's Antiarrhythmic Potential in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Harboring Hypertrophic and Dilated Cardiomyopathy-Related Mutations

Abdelsayed Mena, Mercola Mark, Antzelevitch Charles

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)